Pharmacokinetics of Cefoxitin in Patients Undergoing Hemodialysis
Overview
Pharmacy
Affiliations
The parmacokinetics of Cefoxitin were studied after an i.v. administration of 15 mg/kg body weight in 17 patients with terminal renal impairment, 10 of which were undergoing 6 hr hemodialysis sessions. The average pharmokinetic parameters obtained from this kind of patient were the following: alpha = 2.88 hr-1 beta = 0.18 hr-1 K12 = 1.43 hr-1 K21 = 1.04 hr-1 K13 = 0.53 hr-1 Vc = 8.23 l Vp = 11.61 l Vdss = 19.84 l. The amounts of the antibiotic in the central and peripheric compartments are established together with the amount of the antibiotic eliminated as a function of time. The pharmacokinetic parameters are significantly different from those established in the period between dialysis sessions, and thus, the elimination constant reaches a value of 0.28 h-1. The degree of plasma protein binding of Cefoxitin is 41.46% during the hemodialysis sessions. A dosage regimen is programmed as a function of the pharmacokinetic parameters established for this kind of patient. It is recommended that an i.v. dose of 15 mg/kg body weight should be administered at the beginning and end of each dialysis session lasting 6 hours, when the periods between the sessions are 48 hours.
An Overview of the Protein Binding of Cephalosporins in Human Body Fluids: A Systematic Review.
Jongmans C, Muller A, Van Den Broek P, Cruz De Almeida B, van den Berg C, van Oldenrijk J Front Pharmacol. 2022; 13:900551.
PMID: 35837288 PMC: 9274189. DOI: 10.3389/fphar.2022.900551.
Cefoxitin disposition during peritoneal dialysis.
Greaves W, Kreeft J, OGILVIE R, Richards G Antimicrob Agents Chemother. 1981; 19(2):253-5.
PMID: 7347560 PMC: 181403. DOI: 10.1128/AAC.19.2.253.
Disposition of cefoxitin in patients with ascites.
Garcia M, Dominguez-Gil A, Perez F, Rodriguez F, Moronta F Eur J Clin Pharmacol. 1981; 20(5):371-4.
PMID: 7286047 DOI: 10.1007/BF00615407.
Zini R, Riant P, Barre J, Tillement J Clin Pharmacokinet. 1990; 19(3):218-29.
PMID: 2203581 DOI: 10.2165/00003088-199019030-00005.
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.
St Peter W, Halstenson C Clin Pharmacokinet. 1992; 22(3):169-210.
PMID: 1559311 DOI: 10.2165/00003088-199222030-00002.